On Thursday, Relmada Therapeutics' Chief Executive Officer, Sergio Traversa, made a $178,095 buy of RLMD, purchasing 265,976 shares at a cost of $0.67 each. So far Traversa is in the green, up about 119.5% on their purchase based on today's trading high of $1.47. Relmada Therapeutics is trading up about 26.8% on the day Tuesday. Before this latest buy, Traversa purchased RLMD at 2 other times during the past year, for a total investment of $569,827 at an average of $1.16 per share.
And on Friday, CHIEF FINANCIAL OFFICER Daniel Wayne Jackson bought $154,850 worth of Strategic Education, buying 1,900 shares at a cost of $81.50 a piece. Strategic Education is trading up about 0.6% on the day Tuesday.
VIDEO: Tuesday 9/2 Insider Buying Report: RLMD, STRA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
